Indication
B-cell Tumors
2 clinical trials
3 products
Product
SHR1459Clinical trial
Study of the Pharmacokinetic Effects of Efavirenz on the Pharmacokinetics of SHR1459 in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-12-02
Product
EfavirenzClinical trial
An Open Label, Single-site, Dose-escalation Study Aiming to Evaluate the Efficacy and Safety of Anti-CD19 CAR-T Manufactured by OlyCAR Platform(OlyCAR-019) in the Treatment of Relapsed/ Refractory(r/r) B-Cell MalignanciesStatus: Recruiting, Estimated PCD: 2024-06-30